Seres Therapeutics Inc (MCRB)
1.16
+0.05
(+4.50%)
USD |
NASDAQ |
May 03, 16:00
1.16
0.00 (0.00%)
After-Hours: 20:00
Seres Therapeutics Max Drawdown (5Y): 98.52% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 98.52% |
March 31, 2024 | 98.01% |
February 29, 2024 | 97.53% |
January 31, 2024 | 97.53% |
December 31, 2023 | 97.53% |
November 30, 2023 | 97.53% |
October 31, 2023 | 96.54% |
September 30, 2023 | 95.56% |
August 31, 2023 | 95.56% |
July 31, 2023 | 95.56% |
June 30, 2023 | 95.56% |
May 31, 2023 | 95.56% |
April 30, 2023 | 95.56% |
March 31, 2023 | 95.56% |
February 28, 2023 | 95.56% |
January 31, 2023 | 95.56% |
December 31, 2022 | 95.56% |
November 30, 2022 | 95.56% |
October 31, 2022 | 95.56% |
September 30, 2022 | 95.56% |
August 31, 2022 | 95.56% |
July 31, 2022 | 95.56% |
June 30, 2022 | 95.56% |
May 31, 2022 | 95.56% |
April 30, 2022 | 95.56% |
Date | Value |
---|---|
March 31, 2022 | 95.56% |
February 28, 2022 | 95.56% |
January 31, 2022 | 95.56% |
December 31, 2021 | 95.56% |
November 30, 2021 | 95.56% |
October 31, 2021 | 95.56% |
September 30, 2021 | 95.56% |
August 31, 2021 | 95.56% |
July 31, 2021 | 95.56% |
June 30, 2021 | 95.56% |
May 31, 2021 | 95.56% |
April 30, 2021 | 95.56% |
March 31, 2021 | 95.56% |
February 28, 2021 | 95.56% |
January 31, 2021 | 95.56% |
December 31, 2020 | 95.56% |
November 30, 2020 | 95.56% |
October 31, 2020 | 95.56% |
September 30, 2020 | 95.56% |
August 31, 2020 | 95.56% |
July 31, 2020 | 95.56% |
June 30, 2020 | 95.56% |
May 31, 2020 | 95.56% |
April 30, 2020 | 95.56% |
March 31, 2020 | 95.56% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
93.37%
Minimum
May 2019
98.52%
Maximum
Apr 2024
95.76%
Average
95.56%
Median
Jun 2019
Max Drawdown (5Y) Benchmarks
Integra Lifesciences Holdings Corp | 63.02% |
Nuwellis Inc | 100.00% |
Axogen Inc | 87.50% |
Axsome Therapeutics Inc | 81.26% |
908 Devices Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -57.54 |
Beta (5Y) | 2.159 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 237.6% |
Historical Sharpe Ratio (5Y) | -0.1409 |
Historical Sortino (5Y) | -0.6527 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.62% |